Delivery Order SPE2DB22D9207-SPE2DB26FH4TR
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $7,174.74 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on September 22, 2025, for the supply of Omidria 1-0.3% vials (4ML). This delivery order is issued under the company's larger single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4 mL) with a contract value of $2,391.60. This firm fixed-price delivery order was awarded on September 5, 2025, with an ultimate completion date of September 26, 2025. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,174.74 on August 4, 2025, for the supply of OMIDRIA 1-0.3% vials (4ml). This firm fixed-price delivery order, issued without a set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and carries an ultimate completion date of August 25, 2025. The award represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency to provide Omidria 1-0.3% Vial 4ML. The delivery order has a potential value of $5,753.55 and a completion date of December 11, 2023. DMS Pharmaceutical Group will supply the pharmaceutical item to DLA Troop Support Medical facilities from its place of performance in Park Ridge, Illinois. As a woman-owned small business and pharmaceutical...
- The Defense Logistics Agency awarded a $2,391.60 delivery order to DMS Pharmaceutical Group Inc. on September 9, 2025, for Omidria 1-0.3% vial 4ML, a pharmaceutical product used during ophthalmic surgery. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $7,466.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 20, 2025, with an ultimate completion date of October 21, 2025, represents one of numerous recent purchases from the vendor without set-aside designation. The award falls under DMS Pharmaceutical Group's single-award...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,737.97, is for the delivery of OMIDRIA 1-0.3% vial, 4 mL, a pharmaceutical product. The contract has a firm fixed price and no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- The Defense Logistics Agency awarded a delivery order valued at $2,961.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 27, 2025, represents a firm fixed-price procurement with an ultimate completion date of October 28, 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery...
- This contract award, valued at $4,983.96, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the pharmaceutical product OMIDRIA 1-0.3% VIAL 4ML, with an ultimate completion date of July 22, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $11,094.20 on October 30, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, without set-aside designation, represents one of numerous purchase orders issued to the vendor in October 2025 for pharmaceutical products and medical consumables to support Department of Defense healthcare...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB26FH4TRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,174.74 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of OMIDRIA 1-0.3% vials (4mL). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation, indicating the contractor competed in an unrestricted procurement. This delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical supply chain support to Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical pharmaceutical supplier within the federal military medical system, with demonstrated performance across diverse product categories including specialty pharmaceuticals, biologics, vaccines, and medical consumables. The company's registration in the System for Award Management since 2001 and its substantial contracting activity with the DLA's Medical Supply Chain division underscore its capability to fulfill specialized pharmaceutical requirements. The PPV-G GEN V contract, which carries a ceiling value of $499,999,999 and extends through December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors supporting the Department of Defense's recurring global medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 10/31/25 |